12.07.2015 Views

05/2009 - Državni zavod za intelektualno vlasništvo

05/2009 - Državni zavod za intelektualno vlasništvo

05/2009 - Državni zavod za intelektualno vlasništvo

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

HR - Patenti - Hrvatski glasnik <strong>intelektualno</strong>g vlasništva 16, <strong>2009</strong>, 5, 1863 – 2065 1983MKP Broj objave europske Naziv izumaprijave patenta(51) (97) (54)A61K 31/197 (2006.01) EP 2<strong>05</strong>4377 * CHEMICAL COMPOUNDSA61K 31/198 (2006.01) EP 2049092 * COMPOSITIONS WITH ENHANCED ELASTICIZING ACTIVITYA61K 31/198 (2006.01) EP 2<strong>05</strong>0446 * SULFONAMIDE COMPOUND OR SALT THEREOFA61K 31/20 (2006.01) EP 2049098 * OMEGA-3 FATTY ACIDS FOR USE IN TREATING RESISTANT HYPERTENSIONA61K 31/2<strong>05</strong> (2006.01) EP 2046734 * DERIVATIVES OF 4-TRIMETHYLAMMONIUM-3-AMINOBUTYRATE AND 4-TRIMETHYLPHOSPHONIUM-3-AMINOBUTYRATE AS CPT-INHIBITORSA61K 31/216 (2006.01) EP 2<strong>05</strong>0446 * SULFONAMIDE COMPOUND OR SALT THEREOFA61K 31/23 (2006.01) EP 2049092 * COMPOSITIONS WITH ENHANCED ELASTICIZING ACTIVITYA61K 31/235 (2006.01) EP 2<strong>05</strong>0446 * SULFONAMIDE COMPOUND OR SALT THEREOFA61K 31/235 (2006.01) EP 2<strong>05</strong>1958 * PHENYL-PRENYL-ETHER DERIVATIVES FOR THE TREATMENT OF COGNITIVE,NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERSA61K 31/24 (2006.01) EP 2<strong>05</strong>0446 * SULFONAMIDE COMPOUND OR SALT THEREOFA61K 31/27 (2006.01) EP 1972616Derivatives of arylalkylcarbamates, process for their preparation and therapeutic applicationthereofA61K 31/27 (2006.01) EP 2<strong>05</strong>3038 * AMINOALCOHOL DERIVATIVE AND IMMUNOSUPPRESSANT CONTAINING THE SAME ASAN ACTIVE INGREDIENTA61K 31/275 (2006.01) EP 2<strong>05</strong>0446 * SULFONAMIDE COMPOUND OR SALT THEREOFA61K 31/282 (2006.01) EP 1967189 Methods for treating resistant or refractory tumorsA61K 31/33 (2006.01) EP 2046121 * FATTY ACID PHARMACEUTICAL FOAMA61K 31/33 (2006.01) EP 2049481 * NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS FOR OPIOIDRECEPTORSA61K 31/337 (2006.01) EP 2049155 * ANTITUMOR COMBINATIONS CONTAINING TAXANE DERIVATIVESA61K 31/341 (2006.01) EP 2<strong>05</strong>0446 * SULFONAMIDE COMPOUND OR SALT THEREOFA61K 31/341 (2006.01) EP 2<strong>05</strong>1707 * INHIBITORS OF PLASMA KALLIKREINA61K 31/343 (2006.01) EP 2<strong>05</strong>0446 * SULFONAMIDE COMPOUND OR SALT THEREOFA61K 31/352 (2006.01) EP 2046769 * ALDH-2 INHIBITORS IN THE TREATMENT OF ADDICTIONA61K 31/365 (2006.01) EP 2<strong>05</strong>3393 * PLADIENOLIDE TARGET MOLECULE, COMPOUND CAPABLE OF BINDING TO THETARGET MOLECULE, AND SCREENING METHOD FOR THE COMPOUNDA61K 31/381 (2006.01) EP 2<strong>05</strong>0446 * SULFONAMIDE COMPOUND OR SALT THEREOFA61K 31/381 (2006.01) EP 2<strong>05</strong>1707 * INHIBITORS OF PLASMA KALLIKREINA61K 31/381 (2006.01) EP 2<strong>05</strong>1974 * TETRAHYDROBENZOTHIOPHENE DERIVATIVESA61K 31/397 (2006.01) EP 2049472 * CYCLOPROPYL AMINE DERIVATIVES AS HISTAMIN H3 RECEPTOR MODULATORSA61K 31/40 (2006.01) EP 2049479 * POLYMORPHS OF ATORVASTATIN SODIUM AND MAGNESIUM SALTSA61K 31/40 (2006.01) EP 2049484 * ISOINDOLINE DERIVATIVES FOR THE TREATMENT OF ARRHYTHMIASA61K 31/40 (2006.01) EP 2<strong>05</strong>0446 * SULFONAMIDE COMPOUND OR SALT THEREOFA61K 31/40 (2006.01) EP 2<strong>05</strong>1707 * INHIBITORS OF PLASMA KALLIKREINA61K 31/4015 (2006.01) EP 2049104 * PYRROLIDINONE ANILINES AS PROGESTERONE RECEPTOR MODULATORSA61K 31/4015 (2006.01) EP 2049478 * SUBSTITUTED N-PHENYLMETHYL -5-OXO-PROLINE-2-AMIDES AS P2X7-RECEPTORANTAGONISTS AND THEIR METHODS OF USEA61K 31/4015 (2006.01) EP 2049485 * NAPHTHALENE DERIVATIVES USED AS EP4 RECEPTOR AGONISTSA61K 31/4015 (2006.01) EP 2<strong>05</strong>0446 * SULFONAMIDE COMPOUND OR SALT THEREOFA61K 31/402 (2006.01) EP 2049478 * SUBSTITUTED N-PHENYLMETHYL -5-OXO-PROLINE-2-AMIDES AS P2X7-RECEPTORANTAGONISTS AND THEIR METHODS OF USEA61K 31/4025 (2006.01) EP 2046779 * MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY, CRYSTALLINE FORMS ANDPROCESSA61K 31/4025 (2006.01) EP 2049472 * CYCLOPROPYL AMINE DERIVATIVES AS HISTAMIN H3 RECEPTOR MODULATORSA61K 31/4025 (2006.01) EP 2049477 * MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY, CRYSTALLINE FORMS ANDPROCESSA61K 31/4025 (2006.01) EP 2049519 * CYCLIC DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITYA61K 31/4025 (2006.01) EP 2049522 * HEPATITIS C VIRUS INHIBITORSA61K 31/403 (2006.01) EP 2<strong>05</strong>4<strong>05</strong>4 * USE OF AZABICYCLO HEXANE DERIVATIVESA61K 31/4035 (2006.01) EP 2049484 * ISOINDOLINE DERIVATIVES FOR THE TREATMENT OF ARRHYTHMIASA61K 31/4035 (2006.01) EP 2049524 * IAP INHIBITORSA61K 31/4035 (2006.01) EP 2<strong>05</strong>0448 * ORAL DISINTEGRATING TABLET HAVING MASKED BITTER TASTE AND METHOD FORPRODUCTION THEREOFA61K 31/4035 (2006.01) EP 2<strong>05</strong>1961 * NOVEL ISOINDOL DERIVATIVES AS EP4 RECEPTOR AGONISTSA61K 31/404 (2006.01) EP 2<strong>05</strong>0446 * SULFONAMIDE COMPOUND OR SALT THEREOFA61K 31/41 (2006.01) EP 2049484 * ISOINDOLINE DERIVATIVES FOR THE TREATMENT OF ARRHYTHMIASA61K 31/415 (2006.01) EP 1953144Novel polymorphic forms of N-piperidino-5-(4-chlorophenyl)-1-(2, 4-dichlorphenyl)-4-methyl-3-pyrazolecarboxamideA61K 31/415 (2006.01) EP 2<strong>05</strong>0446 * SULFONAMIDE COMPOUND OR SALT THEREOFA61K 31/415 (2006.01) EP 2<strong>05</strong>1707 * INHIBITORS OF PLASMA KALLIKREINISSN 1331-2030

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!